Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Introduction to Market Drivers and Restraints
4.3 Market Drivers
4.3.1 Availability of Skilled Labor at Relatively Lower Cost
4.3.2 Increasing Outsourcing Volume by Big Pharma Companies
4.4 Market Restraints
4.4.1 Recent Quality and Regulatory Issues Fueling Apprehension
4.5 Market Opportunities
4.5.1 Large Manufacturers Leveraging their Scale and Custom Synthesis Capabilities for Expansion
4.6 Overview of the Pharmaceutical Sector in India
4.7 Industry Value Chain Analysis
4.8 Industry Attractiveness - Porter’s Five Force Analysis
4.8.1 Threat of New Entrants
4.8.2 Bargaining Power of Buyers/Consumers
4.8.3 Bargaining Power of Suppliers
4.8.4 Threat of Substitute Products
4.8.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Service Type
5.1.1 API and Intermediates
5.1.2 Finished Dose
5.1.2.1 Injectable
5.1.2.2 Liquid and Semi-solid
5.1.2.3 Solids


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 AMRI India Pvt. Ltd.
6.1.2 Dr. Reddy’s Laboratories
6.1.3 Cadila Healthcare Limited
6.1.4 MSN Laboratories Pvt Ltd.
6.1.5 Mylan Laboratories Ltd.
6.1.6 Medipaams India Pvt Ltd.
6.1.7 Cipla Ltd.
6.1.8 Eisai Pharmaceuticals India Pvt Ltd.
6.1.9 Delwis Healthcare Pvt Ltd.
6.1.10 Maxheal Pharmaceuticals India Ltd.
6.1.11 Rhydburg Pharmaceuticals Ltd.
*List not Exhaustive


7 COMPARATIVE ANALYSIS OF VENDORS


8 INVESTMENT ANALYSIS


9 MARKET OPPORTUNITIES AND FUTURE TRENDS